Therapeutic response of rosacea to dobesilate

European Journal of Medical Research

Volumn 10, Issue 10, 2005, Pages 454-456

  Cuevas, Pedro ^a   Arrazola, J M ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Dobesilate; Rosacea; Topical therapy

Indexed keywords

DOBESILATE CALCIUM; FIBROBLAST GROWTH FACTOR; HYDROXYPROPYLCELLULOSE; MACROGOL DERIVATIVE; PROPYLENE GLYCOL; WATER;

ADULT; ANGIOGENESIS; ARTICLE; CASE REPORT; DRUG FORMULATION; DRUG RESPONSE; FEMALE; FLUSHING; HUMAN; MOTIVATION; OINTMENT; PATIENT COMPLIANCE; PHOTOGRAPHY; ROSACEA; SKIN BURNING SENSATION; SKIN MANIFESTATION;

ADMINISTRATION, TOPICAL; ADULT; ANGIOGENESIS INHIBITORS; CALCIUM DOBESILATE; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; OINTMENTS; ROSACEA;

EID: 27744572068     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Crawford GH, Pelle MT, James WD (2004) Rosacea: I Etiology, pathogenesis and subtype classification. J Am Acad Dermatol 51: 327-341
2. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptor in psoriasis. J. Exp. Med 180: 1141-1146
3. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1: 27-31
4. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HR, Van der Water L (1995) Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 154: 2801-2807
5. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumor progression. Cell 86: 353-364
6. Paques M, Massin P, Gaudric A (1997) Growth factors and diabetic retinopathy. Diabetes Metab 23: 125-130
7. Pels K, labinaz M, O'Brien ER (1997) Arterial wall neovascularization. Potential role in atherosclerosis and restenosis. Jpn Circ J 61: 893-904
8. Mihalich A, Reina M, Mangioni S, Ponti E, Alberti L, Vigano P, Vignali M, Di Blasio AM (2003) Different basic fibroblast growth factor and fibroblast growth factor-antisense expression in eutopic endometrial stroma cells derived from women with and without endometriosis. J Clin Endocrinol Metab 88: 2853-2859
9. Brakenhielm E, Cao R, Gao B, Angelin B, Canon B, Parini P, Cao Y (2004) Angiogenesis inhibitor, TPN-470, prevents diet-induced and genetic obesity in mice. Circ Res 94: 1579-88
10. Giménez-Gallego G, Cuevas P. (1994) Fibroblast growth factors, proteins with a broad spectrum of biological activities. Neurol Res 16: 313-316
11. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ (1994) Vascular endothelial growth factor and its receptors. Prog. Growth Fact Res 5: 89-97
12. Eskens FA (2004) Angiogenesis inhibitors in clinical development: where are we now and where are we going? Br J Cancer 90: 1-7
13. Sibenge S, Gawkrodger DJ (1992) Rosacea: a study of clinical patterns, blood flow and the role of Demodex folliculorum. J Am Acad Dermatol 26: 590-593
14. Wilking JK (1994) Rosacea. Pathophysiology and treatment. Arch Dermatol 130: 359-362
15. Neuman E, Frithz A (1998) Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea. Int J Dermatol 37: 263-266
16. Lachgar S, Charvérou M, Gall Y, Bonafé JL (1999) Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology 199 (Suppl 1) 25-27
17. Bushan M, Young HS, Brenchley PEC, Griffiths CEM (2002) Recent advances in cutaneous angiogenesis. Br J Dermatol 147: 418-425
18. Redondo P, Sánchez-Carpintero I, Bauzá A, Idoate M, Solano T, Mihm MC (2003) Inmunologic scape and angiogenesis in human malignant melanoma. J Am Acad Dermatol 49: 255-263
19. Gira AK, Brown LF, Washington CV, Cohen C, Arbiser JL (2004) Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 50: 850-853
20. Berthet Ph, Farine JC, Borras JP (1999) Calcium dobesilate (Doxium®). Pharmacological profile related to its use in diabetic retinopathy. Int J Clin Pract 53: 631-636
21. Cuevas P, Díaz-González D, Dujovny M (2005) Dihidroxy-2,5 benzenesulfonate (dobesilate) elicits growth arrest and apoptosis in glioma cells. Neurol Res (in press).
22. Carmeliet P (2000) Mechanisms of angiogenesis and atherogenesis. Nat Med 6: 389-395
23. Stavri GF, Zachary IC, Barkerville PA, Martin JF, Ernsalinski JD (1995) Basic fibroblast growth factor upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92: 11-14
24. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998). Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141: 1659-1673
25. Saadeh PB, Mehrara BJ, Steinbrech DS, Spector JA, Greenwald JA, Chin GS, Ueno H, Gittes GK, Longaker MT (2000) Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoclastic cells. Endocrinology 141: 2075-2083
26. Claffey KP, Abrams K, Shih SC, Browh LF, Mullen A, Lough M (2001) Fibroblast growth factor-2 activation of stromal cells vascular endothelial growth factor expression and angiogenesis. Lab Invest 81: 61-75
27. Sako A, Kitayama J, Yamaguchi H, Kaisaki S, Suzuki H, Fukatsu K, Fujii S, Nagawa H (2003) Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2. Possible role of mesothelial cells on the development of peritoneal metastasis. J Surg Res 115: 113-120
28. Ryuto M, Ono M, Izumi H, Yoshiba S, Weich HA, Kohno K, Kuwano M (1996) Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 271: 28220-28228
29. Pepper MS, Ferrara N, Orci L, Montesano P (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochern Biophys Res Commun 189: 824-831
30. Goto F, Goto K, Weindel K, Folkman J (1993) Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69: 508-517
31. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P. (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (BEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141: 1659-1673
32. Compagni A, Wilgenbus P, Impagnatiello M-A, Cotten M, Christofori G (2000) Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 60: 7163-7169
33. Piller NB (1990) Assessment of the anti-inflammatory action of calcium dobesilate. Effect on macrophage attaching to subcutaneously implanted coverslip in guinea pigs. Arzneimitelforschung 40: 698-700
34. Araki S, Shimada Y, Kaji K, Hayashi H (1990) Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 168: 1194-1200
35. Cuevas P, Reimers D, Díaz D, Lozano RM, Giménez-Gallego G (1999) Apoptosis of glioma cells induced by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate. Neurosci Lett 275: 149-151